Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab
2020 ◽
Vol 21
(4)
◽
2021 ◽
pp. 194016122110180
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):